HIGHLIGHTS
- who: Kyung Jae Lee and colleagues from the Department of Pediatrics, Hallym University Sacred Heart Hospital, Anyang , have published the research: Neutralizing Antibody Response, Safety, and Efficacy of mRNA COVID-19 Vaccines in Pediatric Patients with Inflammatory Bowel Disease: A Prospective Multicenter Case—Control Study, in the Journal: Vaccines 2022, 10, 1265. of 17/03/2022
- what: Only one study was conducted to evaluate the immunogenicity in pediatric IBD patients, which compared those treated with infliximab and vedolizumab (gut-selective anti-integrin α4ß7 monoclonal antibody), excluding those who were taking other immunosuppressive drugs . The . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.